BioVie Awarded up to $13.1 Million in Funding From U.S. Department of Defense to Evaluate Bezisterim (Ne3107) for the Treatment of Long Covid
BioVie获得了美国国防部高达1310万美元的资助,用于评估Bezisterim(Ne3107)治疗长期冠状病毒的疗法
BioVie Awarded up to $13.1 Million in Funding From U.S. Department of Defense to Evaluate Bezisterim (Ne3107) for the Treatment of Long Covid
BioVie获得了美国国防部高达1310万美元的资助,用于评估Bezisterim(Ne3107)治疗长期冠状病毒的疗法
使用浏览器的分享功能,分享给你的好友吧